Pharmacoepidemiology and Drug Safety

Cover image for Vol. 20 Issue 5

May 2011

Volume 20, Issue 5

Pages 441–549

  1. Original Reports

    1. Top of page
    2. Original Reports
    3. Commentaries
    1. Patient characteristics and process factors associated with antipsychotic polypharmacy in a nationwide sample of psychiatric inpatients in Italy (pages 441–449)

      Giovanni Santone, Cesario Bellantuono, Paola Rucci, Angelo Picardi, Antonio Preti and Giovanni de Girolamo

      Version of Record online: 23 DEC 2010 | DOI: 10.1002/pds.2083

    2. Utilization of anti-Parkinson drugs in Australia: 1995–2009 (pages 450–456)

      Samantha A Hollingworth, Amanda Rush, Wayne D Hall and Mervyn J Eadie

      Version of Record online: 15 FEB 2011 | DOI: 10.1002/pds.2114

    3. Prevalence, incidence and persistence of etanercept and adalimumab in Norway 2005–2009 (pages 457–463)

      Milada Mahic, Svetlana Skurtveit, Randi Selmer, Marit Rønning and Kari Furu

      Version of Record online: 30 DEC 2010 | DOI: 10.1002/pds.2091

    4. Management of cannabis use during pregnancy: an assessment of healthcare professionals' practices (pages 464–473)

      Marie Gérardin, Caroline Victorri-Vigneau, Cécile Louvigné, Marion Rivoal and Pascale Jolliet

      Version of Record online: 10 JAN 2011 | DOI: 10.1002/pds.2095

    5. Off label use of prescription medicines in children in outpatient setting in Estonia is common (pages 474–481)

      Jana Lass, Alar Irs, Heti Pisarev, Triin Leinemann and Irja Lutsar

      Version of Record online: 18 MAR 2011 | DOI: 10.1002/pds.2125

    6. General practitioners' prescribing patterns for the elderly in a province of Iran (pages 482–487)

      Hadi Ghadimi, Hamideh M. Esmaily and Rolf Wahlstrom

      Version of Record online: 18 JAN 2011 | DOI: 10.1002/pds.2106

    7. Drug utilization and polypharmacy in an Italian elderly population: the EPIFARM-elderly project (pages 488–496)

      Alessandro Nobili, Carlotta Franchi, Luca Pasina, Mauro Tettamanti, Marta Baviera, Lara Monesi, Carla Roncaglioni, Emma Riva, Ugo Lucca, Angela Bortolotti, Ida Fortino and Luca Merlino

      Version of Record online: 24 JAN 2011 | DOI: 10.1002/pds.2108

    8. Cholinesterase inhibitor use in Alzheimer's disease: the EPIFARM-Elderly Project (pages 497–505)

      Carlotta Franchi, Ugo Lucca, Mauro Tettamanti, Emma Riva, Ida Fortino, Angela Bortolotti, Luca Merlino, Luca Pasina and Alessandro Nobili

      Version of Record online: 23 MAR 2011 | DOI: 10.1002/pds.2124

    9. Clinical characteristics of patients with drug hypersensitivity in Norway: a single-centre study (pages 506–513)

      Fatemeh Chalabianloo, Aud Berstad, Jan Schjøtt, Bettina Riedel, Ågot Irgens and Erik Florvaag

      Version of Record online: 29 MAR 2011 | DOI: 10.1002/pds.2134

    10. Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK (pages 523–531)

      David J McLernon, Christine M Bond, Amanda J Lee, Margaret C Watson, Philip C Hannaford, Heather Fortnum, Janet Krska, Claire Anderson, Elizabeth Murphy, Anthony Avery and on behalf of the Yellow Card Study Collaboration

      Version of Record online: 17 FEB 2011 | DOI: 10.1002/pds.2117

    11. Safety profile of oseltamivir during the 2009 influenza pandemic (pages 532–543)

      Barbara Donner, Silvia Bader-Weder, Roman Schwarz, Michael M. Peng, James Robert Smith and Viswanathan Niranjan

      Version of Record online: 29 MAR 2011 | DOI: 10.1002/pds.2136

  2. Commentaries

    1. Top of page
    2. Original Reports
    3. Commentaries